Report #2890307

Received Mar 23, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (2)

COVID-19Pyrexia

Symptom narrative

COVID-19; This non-serious case was reported by a nurse via interactive digital media and described the occurrence of covid-19 in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced covid-19 (Verbatim: COVID-19). The outcome of the covid-19 was resolved. It was unknown if the reporter considered the covid-19 to be related to Shingrix. It was unknown if the company considered the covid-19 to be related to Shingrix. Additional Information: GSK Receipt Date: 12-MAR-2026 The patient got the shingles vaccine in early 2022 and then got a fever. The reporter and all other thought it was super normal but it was turns out she had covid. The reporter said that just love it when 2 things can be true at the same time. The batch number was not provided and we and unable to contact the reporter.